Literature DB >> 30515624

Molecular Imaging of Neuroinflammation in HIV.

Anna Boerwinkle1, Beau M Ances2,3.   

Abstract

The development of combined antiretroviral therapy (cART) has increased the lifespan of persons living with HIV (PLWH), with most PLWH having a normal life expectancy. While significant progress has occurred, PLWH continue to have multiple health complications, including HIV associated neurocognitive disorders (HAND). While the exact cause of HAND is not known, persistent neuroinflammation is hypothesized to be an important potential contributor. Molecular imaging using positron emission tomography (PET) can non-invasively evaluate neuroinflammation. PET radiotracers specific for increased expression of the translocator protein18kDa (TSPO) on activated microglia can detect the presence of neuroinflammation in PLWH. However, results from these studies have been inconsistent and inconclusive. Future studies are needed to address key limitations that continue to persist with these techniques before accurate conclusions can be drawn regarding the role of persistent neuroinflammation in PLWH.

Entities:  

Keywords:  (TSPO); HIV-associated neurocognitive impairment (HAND); Human immunodeficiency virus (HIV); Neuroinflammation; Positron emission tomography (PET); Translocator protein 18 kDa

Mesh:

Substances:

Year:  2018        PMID: 30515624      PMCID: PMC6391180          DOI: 10.1007/s11481-018-9823-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  36 in total

Review 1.  Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap.

Authors:  Justin C McArthur; Joseph Steiner; Ned Sacktor; Avi Nath
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

2.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

3.  Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

Authors:  F Cicchetti; A L Brownell; K Williams; Y I Chen; E Livni; O Isacson
Journal:  Eur J Neurosci       Date:  2002-03       Impact factor: 3.386

4.  Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity.

Authors:  A C Kuhlmann; T R Guilarte
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

5.  Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.

Authors:  Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

6.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS.

Authors:  Dima A Hammoud; Christopher J Endres; Ankit R Chander; Tomas R Guilarte; Dean F Wong; Ned C Sacktor; Justin C McArthur; Martin G Pomper
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.

Authors:  Balázs Gulyás; Boglárka Makkai; Péter Kása; Károly Gulya; Lidia Bakota; Szilvia Várszegi; Zsuzsa Beliczai; Jan Andersson; László Csiba; Andrea Thiele; Thomas Dyrks; Tetsua Suhara; Kazutoshi Suzuki; Makato Higuchi; Christer Halldin
Journal:  Neurochem Int       Date:  2008-10-15       Impact factor: 3.921

9.  Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.

Authors:  Fabien Chauveau; Nadja Van Camp; Frédéric Dollé; Bertrand Kuhnast; Françoise Hinnen; Annelaure Damont; Hervé Boutin; Michelle James; Michael Kassiou; Bertrand Tavitian
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

10.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

Authors:  R B Banati; J Newcombe; R N Gunn; A Cagnin; F Turkheimer; F Heppner; G Price; F Wegner; G Giovannoni; D H Miller; G D Perkin; T Smith; A K Hewson; G Bydder; G W Kreutzberg; T Jones; M L Cuzner; R Myers
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

View more
  12 in total

1.  Editor's Commentary for Special Issue: "The Role of Macrophages in HIV Persistence".

Authors:  Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-09       Impact factor: 4.147

Review 2.  The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus.

Authors:  Daniela D'Amico; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Purinergic Signal       Date:  2021-09-20       Impact factor: 3.765

Review 3.  Neuroinflammation in HIV-associated depression: evidence and future perspectives.

Authors:  Arish Mudra Rakshasa-Loots; Heather C Whalley; Jaime H Vera; Simon R Cox
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 13.437

Review 4.  Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders.

Authors:  Elena Irollo; Jared Luchetta; Chunta Ho; Bradley Nash; Olimpia Meucci
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 5.  Seeing Is Believing: Nuclear Imaging of HIV Persistence.

Authors:  Timothy J Henrich; Priscilla Y Hsue; Henry VanBrocklin
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

6.  Predictive biomarkers for cognitive decline during progressive HIV infection.

Authors:  Howard E Gendelman
Journal:  EBioMedicine       Date:  2019-11-14       Impact factor: 8.143

7.  Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection.

Authors:  Farina J Mahmud; Yong Du; Elizabeth Greif; Thomas Boucher; Robert F Dannals; William B Mathews; Martin G Pomper; Polina Sysa-Shah; Kelly A Metcalf Pate; Claire Lyons; Bess Carlson; Maria Chacona; Amanda M Brown
Journal:  J Neuroinflammation       Date:  2020-09-17       Impact factor: 8.322

8.  A longitudinal analysis of brain extracellular free water in HIV infected individuals.

Authors:  Md Nasir Uddin; Abrar Faiyaz; Lu Wang; Yuchuan Zhuang; Kyle D Murray; Maxime Descoteaux; Madalina E Tivarus; Miriam T Weber; Jianhui Zhong; Xing Qiu; Giovanni Schifitto
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

9.  Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals.

Authors:  Anna H Boerwinkle; Jeremy F Strain; Tricia Burdo; John Doyle; Jon Christensen; Yi Su; Julie K Wisch; Sarah A Cooley; Florin Vaida; Mandy D Smith; Hussain Jafri; Robert H Paul; Tammie L S Benzinger; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

10.  Neuroinflammation associates with antioxidant heme oxygenase-1 response throughout the brain in persons living with HIV.

Authors:  Analise L Gruenewald; Yoelvis Garcia-Mesa; Alexander J Gill; Rolando Garza; Benjamin B Gelman; Dennis L Kolson
Journal:  J Neurovirol       Date:  2020-09-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.